PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).

Alexandre Andre Balieiro Anastacio da Costa,Felipe D'Almeida Costa,Andrea Cruz Ferraz de Oliveira,Carlos Stecca,Audrey Oliveira,Ana Caroline Alves,Marcos Pedro Guedes Camandaroba,Daniel Vilarim Araujo,Larissa Machado,Vladmir Cláudio Cordeiro de Lima

PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).

2017

Alexandre Andre Balieiro Anastacio da Costa
Felipe D'Almeida Costa
Andrea Cruz Ferraz de Oliveira
Carlos Stecca
Audrey Oliveira
Ana Caroline Alves
Marcos Pedro Guedes Camandaroba
Daniel Vilarim Araujo
Larissa Machado
Vladmir Cláudio Cordeiro de Lima

6061Background: Platinum-based chemotherapy in association to cetuximab is the standart first-line treatment for metastatic HNSCC. There is no established biomarker for cetuximab efficacy in HNSCC....

Keywords:

Cetuximab
Pathology
PTEN
Head and neck squamous-cell carcinoma
Cancer research
Medicine
Chemotherapy
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations